Taiwan FDA registration 4115bcf3c564faec3f49f839c4a7cf40

"100 first" total tetraiodothyroxine radioimmunoassay reagents

TW: “百首”總四碘甲狀腺素放射免疫分析試劑
Taiwan flagTaiwan·Risk Class 2·DIASOURCE IMMUNOASSAYS S.A.·Registered Oct 21, 2009 – Oct 21, 2029Active
Registration details
Analysis ID
4115bcf3c564faec3f49f839c4a7cf40
Customs Code
DHAS0602039707
Company information
Manufacturer Country
Belgium
Authorized Representative
TAIWAN LIFE SUPPORT SYSTEMS INC.
Product details
Intended Use
Thyroxine (T4) radioimmunoassay reagent for in vitro quantitative detection of human serum.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1710 Total triiodothyroxine test system
Import Information
Imports must be accompanied by a letter of consent (a certificate of approval of the Atomic Energy Commission shall be attached to each batch of imports); input
Dates and status
Registration Date
Oct 21, 2009
Expiry Date
Oct 21, 2029
About this record

Access comprehensive regulatory information for "100 first" total tetraiodothyroxine radioimmunoassay reagents in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4115bcf3c564faec3f49f839c4a7cf40 and manufactured by DIASOURCE IMMUNOASSAYS S.A.. The authorized representative in Taiwan is TAIWAN LIFE SUPPORT SYSTEMS INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices